Tag: Shockwave Medical

Shockwave completes enrolment in study of coronary intravascular lithotripsy

Shockwave Medical has completed enrolment in its US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study—DISRUPT CAD III—for the use of intravascular...

Shockwave commences IVL study to support regulatory approval in Japan

Shockwave Medical has initiated the DISRUPT CAD IV study of its intravascular lithotripsy (IVL) system with the aim of using data from the study...

Shockwave study demonstrates strong safety and procedural success of coronary IVL...

Shockwave Medical, a company which provides intravascular lithotripsy (IVL) to treat complex calcified cardiovascular disease, unveiled the results of the DISRUPT CAD II study,...

Keith Dawkins appointed as chief medical officer at Shockwave Medical

Shockwave Medical has appointed Keith D Dawkins as its chief medical officer. In a press release from the company, Dawkins states: “Given the challenges...

A “crackdown” on alternative access for TAVI

  The transfemoral approach is—by far—the most desirable access route for transcatheter aortic valve implantation (TAVI) for eligible patients; it was used in the TAVI...

Shockwave initiates US pivotal study for coronary intravascular lithotripsy

  Shockwave Medical has initiated its US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) study—DISRUPT CAD III—for the use of Intravascular Lithotripsy (IVL)...

Abiomed invests $15 million in Shockwave Medical

A press release reports that Abiomed is to invest US$15 million in Shockwave Medical and the two companies will collaborate on a training and...

Intravascular Lithotripsy for coronary artery disease launched in Europe

Intravascular Lithotripsy (Shockwave Medical) is now available, on the European market, for the management of calcified coronary artery disease. Additionally, according to a press...

Intravascular lithotripsy: A novel technology for treating calcified coronary stenoses

Intravascular lithotripsy, or IVL (Shockwave), is a novel procedure that is designed to deliver localised pulsatile sonic pressure waves, modifying calcified lesions in a...